Kariofyllis Karamperis

A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study

Jesse J. Swen, Cathelijne H. van der Wouden, Lisanne E. N. Manson et al. · The Lancet · 2023 · 462 citations · Full text

Drug Safety, Adverse Drug Reactions, Pharmacoepidemiology +9

Clinical implementation of preemptive pharmacogenomics in psychiatry

Kariofyllis Karamperis, Margarita-Ioanna Koufaki, Evangelia Eirini Tsermpini et al. · EBioMedicine · 2024 · 49 citations · Full text

Economic evaluation of pharmacogenomic-guided antiplatelet treatment in Spanish patients suffering from acute coronary syndrome participating in the U-PGx PREPARE study

Margarita-Ioanna Koufaki, Vasileios Fragoulakis, Xando Díaz-Villamarín et al. · Human Genomics · 2023 · 30 citations · Full text

Adoption of Pharmacogenomic Testing: A Marketing Perspective

Margarita-Ioanna Koufaki, Kariofyllis Karamperis, Polixeni Vitsa et al. · Frontiers in Pharmacology · 2021 · 21 citations · Full text

Medical Ethics, Marketing Perspective, Health Policy +13

Genetic ancestry in population pharmacogenomics unravels distinct geographical patterns related to drug toxicity

Kariofyllis Karamperis, Sonja Katz, Federico Melograna et al. · iScience · 2024 · 19 citations · Full text

Human Variation, Medicine, Genetics +9